NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

基因治療研發市場(2021-2031):疾病、載體(病毒/非病毒)、技術預測、區域/主要國家市場分析、基因治療先進公司、COVID-19恢復情景

Gene Therapy R&D Market Report 2021-2031: Forecasts by Disease, by Vector (Viral/Non-Viral), by Techniques, Regional & Leading National Market Analysis, Leading Gene Therapy Companies, and COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 1022277
出版日期 內容資訊 英文 475 Pages
商品交期: 最快1-2個工作天內
價格
基因治療研發市場(2021-2031):疾病、載體(病毒/非病毒)、技術預測、區域/主要國家市場分析、基因治療先進公司、COVID-19恢復情景 Gene Therapy R&D Market Report 2021-2031: Forecasts by Disease, by Vector (Viral/Non-Viral), by Techniques, Regional & Leading National Market Analysis, Leading Gene Therapy Companies, and COVID-19 Recovery Scenarios
出版日期: 2021年06月11日內容資訊: 英文 475 Pages
簡介

推動基因治療研發市場增長的因素包括豐富的基因治療管線、大公司的投資增加、靶向疾病治療的滲透率增加以及技術進步。此外,臨床試驗數量的增加和設施的擴張預計將成為有希望的增長機會。

隨著處於臨床階段的初創公司數量增加,基因治療和細胞治療領域的新公司缺乏從依賴早期開發的外包廠商生產病毒載體的能力。隨著這些公司發展到商業規模,他們往往可以完全控制自己的製造,以避免外包的麻煩。因此,生物技術公司現在正在製定增長戰略、組建內部團隊並為現場顧問提供建議。

本報告調查了全球基因治療研發市場,包括市場規模和預測、市場份額、增長和製約因素、挑戰和機遇、疾病/載體/技術/地區/國家市場分析,它提供了諸如主要公司的競爭條件和概況。

目錄

第 1 章報告概述

第 2 章執行摘要

第 3 章市場動態

  • 成長因素
    • 強大的基因治療管道可促進增長
    • 燃料市場增長的技術進步
    • 大公司加大投資力度
    • 提高靶向疾病治療的滲透率
  • 抑制因素/問題
    • 細胞和基因療法針對特定疾病
    • 高成本遏制基因治療研發增長到2031年
    • 挑戰行業增長的監管情景
  • 市場機會
    • 越來越多的臨床試驗提供有利的增長機會
    • 擴建設施有望提供良好的增長前景
  • 行業分析-波特五力分析
  • 行業分析-PEST分析

第 4 章按疾病分類:基因治療研發市場

  • 癌症細分市場預測(2021-2031)
    • 基因治療干預可糾正導致癌症進展的分子缺陷
    • 癌症板塊基因治療研發預測及恢復場景
  • 罕見病細分市場預測(2021-2031)
    • 促進細分增長的罕見病經濟負擔
    • 罕見病領域基因治療研發預測及恢復場景
  • 心血管疾病細分市場預測(2021-2031)
    • 增加促進增長的CVD患者後備群
    • CVD 細分市場的基因治療研發預測和恢復情景
  • 眼科疾病細分市場預測(2021-2031)
    • 基因治療在眼科領域取得進展
    • 眼科疾病板塊基因治療研發預測及恢復情景
  • 血液學細分市場預測(2021-2031)
    • 血液相關疾病負擔的增加促進了細分市場的增長
    • 接受每種基因治療的血液疾病
    • 一家開發血液病基因療法的公司
    • 血液科基因治療研發預測、康復場景
  • 神經病學細分市場預測(2021-2031)
    • 腺相關病毒 (AAV) 載體,一種快速崛起的基因治療平台,用於治療神經系統疾病
    • 神經科基因治療研發預測、康復場景
  • 糖尿病細分市場預測(2021-2031)
    • 糖尿病板塊基因治療研發預測及恢復場景
  • 其他疾病細分市場預測(2021-2031)
    • 其他細分市場的基因治療研發預測和恢復情景

第 5 章Vector:基因治療研發市場

  • 病毒細分市場預測(2021-2031)
    • 主要公司擴建設施以促進病毒細分行業的增長
    • 逆轉錄病毒
    • 腺病毒
    • AAV(腺相關病毒)
    • 慢病毒
    • 其他
    • 病毒片段基因治療研發預測及恢復場景
  • 非病毒細分市場預測(2021-2031)
    • 擴展研究,專注於開發最佳交付方法以推動子細分市場增長
    • 裸 DNA
    • 基因槍
    • 電穿孔
    • 非病毒部分的基因治療研發預測和恢復場景

第 6 章按技術:基因治療研發市場

  • 基因增強治療細分市場預測(2021-2031)
    • 基因增強板塊的基因治療研發預測與恢復場景
  • 基因替代療法細分市場的市場預測(2021-2031)
    • 基因治療研發預測基因置換片段、恢復場景

第 7 章區域和主要國家:基因治療研發市場預測(2021-2031)

  • 按地區劃分:全球基因治療研發市場預測(2021-2031)
  • 按地區劃分:基因治療研發市場預測、復甦情景(2021-2031)

第 8 章北美基因治療研發市場

  • 北美目前主導全球基因治療研發市場
  • 國家基因治療研發市場,預測(2021-2031)
  • 針對北美基因治療研發市場的特定疾病預測
    • 復甦情景:北美基因治療研發市場預測(2021-2031)
  • Vector 對北美基因治療研發市場的預測
    • 復甦情景:北美基因治療研發市場向量預測(2021-2031)
  • 北美基因治療研發市場技術預測
    • 復甦情景:北美基因治療研發市場按技術預測(2021-2031)
  • 美國基因治療研發市場預測(2021-2031)
    • 美國目前主導著北美基因治療研發市場
    • 預計將促進區域增長的遺傳性疾病患病率增加
    • 復甦情景:美國基因療法研發市場預測(2021-2031)
  • 加拿大基因療法研發市場預測(2021-2031)
    • 增加癌症負擔 重要的增長機會來自
    • 到 2031 年,老年人口增加推動基因治療研發需求
    • 復甦情景:加拿大基因療法研發市場預測(2021-2031)

第 9 章歐洲基因治療研發市場

  • 全球第二大基因治療研發產業
  • 國家基因治療研發市場,預測(2021-2031)
  • 按疾病分類的歐洲基因治療研發市場預測
    • 復甦情景:歐洲基因療法研發市場預測(2021-2031)
  • Vector 對歐洲基因治療研發市場的預測
    • 復甦情景:歐洲基因治療研發市場向量預測(2021-2031)
  • 歐洲基因治療研發市場技術預測
    • 復甦情景:歐洲基因治療研發市場按技術預測(2021-2031)
  • 德國基因療法研發市場預測(2021-2031)
    • 德國目前主導歐洲基因治療研發市場
    • 增加老年患者群體以提供良好的增長前景
    • 加大新基因治療管線開發力度,提振德國基因治療研發市場
    • 復甦情景:德國基因治療研發市場預測(2021-2031)
  • 英國基因治療研發市場預測(2021-2031)
    • 增加臨床試驗數量以促進英國基因治療研發市場的增長
    • 增加癌症負擔以促進預測期內的區域增長
    • 到 2031 年促進區域增長的遺傳性疾病負擔增加
    • 復甦情景:英國基因治療研發市場預測(2021-2031)
  • 法國基因療法研發市場預測(2021-2031)
    • 推動法國基因治療研發市場增長的遺傳性疾病發病率增加
    • 癌症發病率上升推動基因治療研發增長
    • 法國各地領先的生物技術公司的存在提供了良好的增長前景
    • 復甦情景:法國基因治療研發市場預測(2021-2031)
  • 意大利基因療法研發市場預測(2021-2031)
    • 意大利基因治療研發市場因醫療成本上漲而激增
    • 意大利基因療法研發見證巨大增長
    • 復甦情景:意大利基因療法研發市場預測(2021-2031)
  • 西班牙基因療法研發市場預測(2021-2031)
    • 增加癌症負擔以促進西班牙基因治療研發行業的增長
    • 復甦情景:西班牙基因療法研發市場預測(2021-2031)
  • 俄羅斯基因療法研發市場預測(2021-2031)
    • 癌症發病率上升推動俄羅斯基因治療研發市場增長
    • 政府重點設立基因治療專項基金,促進區域增長
    • 復甦情景:俄羅斯基因療法研發市場預測(2021-2031)
  • 其他歐洲基因治療研發市場預測(2021-2031)
    • 芬蘭基因療法研發和其他歐洲地區的其他有前景的市場
    • 復甦情景:其他歐洲基因療法研發市場預測(2021-2031)

第 10 章亞太地區基因治療研發市場

  • 到 2031 年,亞太地區的增長率最高
  • 國家基因治療研發市場,預測(2021-2031)
  • 按疾病分類的亞太基因治療研發市場預測
    • 復甦情景:亞太地區基因治療研發市場按疾病預測(2021-2031)
  • Vector 對亞太基因治療研發市場的預測
    • 復甦情景:Vector 對亞太地區基因治療研發市場的預測(2021-2031)
  • 亞太基因治療研發市場技術預測
    • 復甦情景:亞太地區基因治療研發市場技術預測(2021-2031)
  • 日本基因療法研發市場預測(2021-2031)
    • 日本基因治療研發市場2031年復合年增長率最佳
    • 日本政府批准 Zolgensuma,預計將支持區域增長
    • 日本老年人口有望在未來十年提供良好的增長前景
    • 復甦情景:日本基因治療研發市場預測(2021-2031)
  • 中國基因治療研發市場預測(2021-2031)
    • 中國目前佔據亞太地區基因治療研發市場的大部分份額
    • 戰略合作在預測期內重振中國基因治療研發市場
    • 復甦情景:中國基因治療研發市場預測(2021-2031)
  • 印度基因治療研發市場預測(2021-2031)
    • 遺傳性疾病負擔和未滿足的醫療需求推動區域基因治療研發產業增長
    • 印度仍然是基因治療相關研究的主要國家
    • 復甦情景:印度基因療法研發市場預測(2021-2031)
  • 澳大利亞基因療法研發市場預測(2021-2031)
    • 推動澳大利亞基因治療研發市場增長的慢性病增加
    • 澳大利亞目前正在進行基因療法的臨床試驗,以治療各種遺傳健康狀況
    • 復甦情景:澳大利亞基因療法研發市場預測(2021-2031)
  • 其他亞太基因治療研發市場預測(2021-2031)
    • 亞太其他東南亞國家經濟推動基因治療研發產業
    • 復甦情景:其他亞太地區基因治療研發市場預測(2021-2031)

第 11 章拉丁美洲基因治療研發市場

  • 拉美基因治療研發產業,世界新興地區之一
  • 國家基因治療研發市場,預測(2021-2031)
  • 按疾病分類的拉丁美洲基因治療研發市場預測
    • 復甦情景:拉丁美洲基因療法研發市場預測(2021-2031)
  • Vector 對拉丁美洲基因治療研發市場的預測
    • 復甦情景:Vector 對拉丁美洲基因治療研發市場的預測(2021-2031)
  • 拉美基因療法研發市場技術預測
    • 復甦情景:拉丁美洲基因治療研發市場技術預測(2021-2031)
  • 巴西基因療法研發市場預測(2021-2031)
    • 巴西的基因治療研發市場見證了拉丁美洲的最高增長率
    • 復甦情景:巴西基因治療研發市場預測(2021-2031)
  • 墨西哥基因療法研發市場預測(2021-2031)
    • 墨西哥基因療法研發,目前主導拉丁美洲
    • 快速增長的螞蟻老齡化調查提供了良好的增長前景
    • 復甦情景:墨西哥基因療法研發市場預測(2021-2031)
  • 其他拉丁美洲基因治療研發市場預測(2021-2031)
    • 復甦情景:其他拉丁美洲基因療法研發市場預測(2021-2031)

第 12 章中東和非洲基因治療研發市場

  • 擴大慢性病患者群體以推動整個中東和非洲對基因治療研發行業的需求
  • 國家基因治療研發市場,預測(2021-2031)
  • 中東和非洲基因治療研發市場的疾病預測
    • 恢復情景:MEA基因治療研發市場按疾病預測(2021-2031)
  • Vector 對中東/非洲基因治療研發市場的預測
    • 復甦情景:MEA 基因治療研發市場矢量預測(2021-2031)
  • 中東/非洲基因治療研發市場技術預測
    • 恢復情景:MEA基因治療研發市場按技術預測(2021-2031)
  • GCC基因治療研發市場預測(2021-2031)
    • 慢性病負擔加重推動 GCC 基因治療研發市場增長
    • Luxturna 在阿聯酋獲批有望在未來十年推動基因治療研發市場
    • 復甦情景:GCC 基因療法研發市場預測(2021-2031)
  • 南非基因治療研發市場預測(2021-2031)
    • 南非目前主導著MEA基因治療研發市場
    • 投資南非基因治療研發產業,助推區域增長
    • 復甦情景:南非基因療法研發市場預測(2021-2031)
  • 中東/非洲其他中東基因治療研發市場預測(2021-2031)
    • 復甦情景:其他中東/非洲基因治療研發市場預測(2021-2031)

第 13 章競爭形勢

  • 贏得基因治療研發市場的戰略選擇
    • 分散技術風險
    • 如何給患者帶來長期利益
    • 數字功能的構建
    • 為整個價值鏈中的公司提供良好增長前景的併購
  • 細胞和基因治療產品於 2021 年 3 月獲得批准
  • 公司正在進行的基因治療臨床試驗
  • 基因治療公司的市值

第 14 章公司簡介

  • UniQure B.V.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 管道:基因治療
    • 近期趨勢
  • Biogen
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Bluebird Bio
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Spark Therapeutics(羅氏的子公司)
    • 公司快照
    • 公司簡介
    • 產品基準
    • 近期趨勢
  • Bayer
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Pfizer, Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Applied Genetic
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Oxford Biomedica
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品線
    • 近期趨勢
  • GenSight Biologics
    • 公司快照
    • 公司簡介
    • 產品基準
  • Takeda Pharmaceuticals
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Cellectis
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Sangamo Therapeutics, Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • REGENXBIO Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Voyager Therapeutics
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Bristol Myers Squibb
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Benitec BioPharma
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
  • F. Hoffmann-La Roche Ltd.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Novartis Gene Therapies
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
    • 近期趨勢
  • Gilead Lifesciences, Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
  • Sanofi
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2019)
    • 產品基準
    • 近期趨勢
  • Transgene
    • 公司快照
    • 公司簡介
    • 產品基準
  • Calimmune, Inc. (CSL Behiring)
    • 公司快照
    • 公司簡介
    • 產品基準
    • 近期趨勢
  • Astellas Pharma Inc.
    • 公司快照
    • 公司簡介
    • 財務分析(2015-2020)
    • 產品基準
  • American Gene Technologies
    • 公司快照
    • 公司簡介
    • 產品基準
  • Orchard Therapeutics
    • 公司快照
    • 公司簡介
    • 產品基準
    • 近期趨勢

第 15 章結論

  • Visiongain 的結論
  • 給市場公司的建議
  • 主要區域和最佳複合年增長率:總區域快照(2021 年和 2031 年)
目錄
Product Code: PHA1136

Title:
Gene Therapy R&D Market Report 2021-2031
Forecasts by Disease (Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology, Neurological, Diabetes Mellitus, Other Diseases), by Vector (Viral (Retrovirus, Adenovirus, AAV, Lentivirus, Others), Non-Viral (Naked DNA, Gene Gun, Electroporation, Lipofection)), by Techniques (Gene Augmentation Therapy, Gene Replacement Therapy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Gene Therapy Companies AND COVID-19 Recovery Scenarios.

Gene Therapy R&D Market- Our new study reveals trends, R&D progress, and predicted revenues over the next decade

Facility Expansion Anticipated to Offer Lucrative Growth Prospects

The rise in clinical-stage start-ups has resulted in a shortage of viral vector manufacturing capacity among contract manufacturers, which new gene & cell therapy companies rely on for early-stage development. As these businesses grow to commercial size, they often tend to have complete control over their manufacturing to avoid the complications of outsourcing. As a result, biotech companies started to develop growth strategies, organize internal teams, and/or seek site consultant advice.

Gene Therapies to Offer Promising Results for Patients Over the Next Decade

Gene therapies are among the most complicated medical treatments ever invented. They are producing promising results for patients because they are precisely programmed to replace faulty genes or reprogram and redirect immune cells against cancer. Children who are experiencing vision loss that may lead to blindness will be able to change their course. Cancer patients who have exhausted all other choices may be able to reclaim their lives. Although the possibilities provided by gene therapy seem endless, more work remains to be done to tackle more diseases and increase the number of patients that can be treated and cured using these amazing medicines.

Which Factors Are Driving the Growth of Gene Therapy R&D Market?

  • Robust Gene Therapy Pipeline to Boost Growth
  • Increasing Investments by Major Players to Augur Market Growth
  • Growing Prevalence of Targeted Diseases Treatment
  • Technological Advancements to Fuel Market Growth

What are the Opportunities for Gene Therapy R&D Market Players?

  • Growing Number of Clinical Trials to Offer Lucrative Growth Opportunities
  • Facility Expansion Anticipated to Offer Lucrative Growth Prospects

How are prominent players reinforcing their position across the global business?

Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies. See where the expected gains will be. View Visiongain's assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of leading companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and outlook.

Discover how to stay ahead

Our 470+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Gene Therapy R&D Market. See how to exploit the opportunities.

Gene Therapy R&D Market Segmentation

Disease

  • Cancer
  • Rare Diseases: Oncologic, Non-Oncologic
  • Cardiovascular Diseases
  • Ophthalmic Diseases
  • Hematology
  • Neurological
  • Diabetes Mellitus
  • Other Diseases

Vector

  • Viral
    • Retrovirus
    • Adenovirus
    • AAV
    • Lentivirus
    • Others
  • Non-Viral
    • Naked DNA
    • Gene Gun
    • Electroporation
    • Lipofection

Techniques

  • Gene Augmentation Therapy
  • Gene Replacement Therapy

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

COVID-19 Impact Recovery Scenarios

This report includes Baseline Forecasts along with Different Rebound Scenarios to help analyze the global Gene Therapy R&D market-no matter how COVID-19 affects the economy.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.

Leading countries and the potential for market growth

Overall world revenue for Gene Therapy R&D market will surpass US$xx in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Gene Therapy R&D Market report helps you

In summary, our 480+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Gene Therapy R&D Market, with forecasts for production process, application, product, and material, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 16 key national markets- See forecasts for the Gene Therapy R&D market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Also forecasted is the market in the US, Canada, Germany, UK, France, Italy, Russia, Japan, China, India, Australia, Brazil, Mexico, GCC, and South Africa among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 16 of the major companies involved in the Gene Therapy R&D Market. Some of the companies profiled in this report are UniQure B. V., Biogen, Bluebird Bio, Spark Therapeutics (Subsidiary of Roche), Bayer, Pfizer, Inc., Applied Genetic, Oxford Biomedica, GenSight Biologics, Takeda Pharmaceuticals, Cellectis, Sangamo Therapeutics, Inc., REGENXBIO Inc., Voyager Therapeutics, Bristol Myers Squibb, Benitec BioPharma, F. Hoffmann-La Roche Ltd., Novartis AG, Gilead Lifesciences, Inc., Sanofi, Transgene, Calimmune, Inc. (CSL Behiring), Astellas Pharma Inc., American Gene Technologies, and Orchard Therapeutics among other prominent players.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. <>Visiongain's study is for everybody needing commercial analyses for the Gene Therapy R&D Market and leading companies. You will find data, trends, and predictions.

Buy our report today“ Gene Therapy R&D Market Report 2021-2031: Forecasts by Disease (Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology, Neurological, Diabetes Mellitus, Other Diseases), by Vector (Viral (Retrovirus, Adenovirus, AAV, Lentivirus, Others), Non-Viral (Naked DNA, Gene Gun, Electroporation, Lipofection)), by Techniques (Gene Augmentation Therapy, Gene Replacement Therapy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Gene Therapy Companies AND COVID-19 Recovery Scenarios. ” Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 Introduction to Gene Therapy R&D Market
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered By This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 COVID-19 Impact: Recovery Scenarios
    • 1.6.2 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Executive Summary

  • 2.1 Gene Therapy Has Experienced a Renaissance in Last 5 Years

3 Market Dynamics

  • 3.1 Drivers
    • 3.1.1 Robust Gene Therapy Pipeline to Boost Growth
    • 3.1.2 Technological Advancements to Fuel Market Growth
    • 3.1.3 Increasing Investments by Major Players
    • 3.1.4 Growing Prevalence of Targeted Diseases Treatment
  • 3.2 Restraints/Challenges
    • 3.2.1 Cell & Gene Therapies Target Specific Diseases
    • 3.2.2 High Cost to Stifle Gene Therapy R&D Growth Through 2031
    • 3.2.3 Regulatory Scenarios to Challenge Industry Growth
  • 3.3 Opportunities
    • 3.3.1 Growing Number of Clinical Trials to Offer Lucrative Growth Opportunities
    • 3.3.2 Facility Expansion Anticipated to Offer Lucrative Growth Prospects
  • 3.4 Industry analysis - Porter's
    • 3.4.1 Buyer Power
    • 3.4.2 Supplier Power
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitute
    • 3.4.5 Threat of New Entrants
  • 3.5 Industry analysis - PEST Analysis
    • 3.5.1 Political Factors Impacting Gene Therapy R&D Market
    • 3.5.2 Economic Factors Impacting Gene Therapy R&D Market
    • 3.5.3 Social Factors Impacting Gene Therapy R&D Market
    • 3.5.4 Technological Factors Impacting Gene Therapy R&D Market

4 Gene Therapy R&D Market by Disease

  • 4.1 Cancer Segment Market Forecast, 2021-2031
    • 4.1.1 Gene Therapy Interventions Have the Potential to Correct Molecular Defects That Contribute to Cancer Progression
    • 4.1.2 Gene Therapy R&D Forecast for Cancer Segment, Recovery Scenarios (V, U, W, L)
  • 4.2 Rare Diseases Sub-Segment Market Forecast, 2021-2031
    • 4.2.1 Economic Burden of Rare Diseases to Fuel Segmental Growth
    • 4.2.2 Gene Therapy R&D Forecast for Rare Diseases Segment, Recovery Scenarios (V, U, W, L)
  • 4.3 Cardiovascular Diseases Segment Market Forecast, 2021-2031
    • 4.3.1 Rising CVDs Patient Pool to Augur Segmental Growth
    • 4.3.2 Gene Therapy R&D Forecast for CVDs Segment, Recovery Scenarios (V, U, W, L)
  • 4.4 Ophthalmic Diseases Segment Market Forecast, 2021-2031
    • 4.4.1 Gene Therapy Making Progress in Ophthalmology
    • 4.4.2 Gene Therapy R&D Forecast for Ophthalmic Diseases Segment, Recovery Scenarios (V, U, W, L)
  • 4.5 Hematology Segment Market Forecast, 2021-2031
    • 4.5.1 Growing Burden of Blood Related Disorders to Boost Segment Growth
    • 4.5.2 Selected Gene Therapy Amenable Hematological Disorders
    • 4.5.3 Companies Developing Gene Therapies for Hematological Disorders
    • 4.5.4 Gene Therapy R&D Forecast for Hematology Segment, Recovery Scenarios (V, U, W, L)
  • 4.6 Neurological Segment Market Forecast, 2021-2031
    • 4.6.1 Adeno-associated viral (AAV) vectors are a rapidly emerging gene therapy platform for the treatment of neurological diseases
    • 4.6.2 Gene Therapy R&D Forecast for Neurological Segment, Recovery Scenarios (V, U, W, L)
  • 4.7 Diabetes Mellitus Segment Market Forecast, 2021-2031
    • 4.7.1 Gene Therapy R&D Forecast for Diabetes Mellitus Segment, Recovery Scenarios (V, U, W, L)
  • 4.8 Other Diseases Segment Market Forecast, 2021-2031
    • 4.8.1 Gene Therapy R&D Forecast for Others Segment, Recovery Scenarios (V, U, W, L)

5 Gene Therapy R&D Market by Vector

  • 5.1 Viral Sub-Segment Market Forecast, 2021-2031
    • 5.1.1 Facility Expansion by Major Players to Fuel Viral Sub-Segment Industry Growth
    • 5.1.2 Retrovirus
    • 5.1.3 Adenovirus
    • 5.1.4 AAV (Adeno-Associated Virus)
    • 5.1.5 Lentivirus
    • 5.1.6 Others
    • 5.1.7 Gene Therapy R&D Forecast for Viral Segment, Recovery Scenarios (V, U, W, L)
  • 5.2 Non-Viral Sub-Segment Market Forecast, 2021-2031
    • 5.2.1 Growing Research Focus on Developing Optimal Delivery Method to Fuel Sub-Segment Growth
    • 5.2.2 Naked DNA
    • 5.2.3 Gene-Gun
    • 5.2.4 Electroporation
    • 5.2.5 Gene Therapy R&D Forecast for Non-Viral Segment, Recovery Scenarios (V, U, W, L)

6 Gene Therapy R&D Market by Techniques

  • 6.1 Gene Augmentation Therapy Segment Market Forecast, 2021-2031
    • 6.1.1 Gene Therapy R&D Forecast for Gene Augmentation Segment, Recovery Scenarios (V, U, W, L)
  • 6.2 Gene Replacement Therapy Segment Market Forecast, 2021-2031
    • 6.2.1 Gene Therapy R&D Forecast for Gene Replacement Segment, Recovery Scenarios (V, U, W, L)

7 Regional and Leading National Gene Therapy R&D Market Forecasts 2021-2031

  • 7.1 Global Gene Therapy R&D Market by Region Forecast 2021-2031
  • 7.2 Recovery Scenarios (V, U, W, L): Gene Therapy R&D Market Forecast by Region, 2021-2031

8 North America Gene Therapy R&D Market

  • 8.1 North America Currently Dominates the Global Gene Therapy R&D Market
  • 8.2 North America Gene Therapy R&D Market by Country, Forecast 2021-2031
  • 8.3 North America Gene Therapy R&D Market Forecast by Disease
    • 8.3.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Disease, 2021-2031
  • 8.4 North America Gene Therapy R&D Market Forecast by Vector
    • 8.4.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Vector, 2021-2031
  • 8.5 North America Gene Therapy R&D Market Forecast by Techniques
    • 8.5.1 Recovery Scenarios (V, U, W, L): North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031
  • 8.6 U.S. Gene Therapy R&D Market Forecast, 2021-2031
    • 8.6.1 U.S. Currently Dominating the North American Gene Therapy R&D Market
    • 8.6.2 Increasing Prevalence of Genetic Disorders Anticipated to Fuel Regional Growth
    • 8.6.3 Recovery Scenarios (V, U, W, L): U.S. Gene Therapy R&D Market Forecast, 2021-2031
  • 8.7 Canada Gene Therapy R&D Market Forecast, 2021-2031
    • 8.7.1 Significant Growth Opportunities Due to Increasing Cancer Burden
    • 8.7.2 Growing Geriatric Population to Fuel Demand for Gene Therapy R&D Through 2031
    • 8.7.3 Recovery Scenarios (V, U, W, L): Canada Gene Therapy R&D Market Forecast, 2021-2031

9 Europe Gene Therapy R&D Market

  • 9.1 Second Largest Gene Therapy R&D Industry Worldwide
  • 9.2 Europe Gene Therapy R&D Market by Country, Forecast 2021-2031
  • 9.3 Europe Gene Therapy R&D Market Forecast by Disease
    • 9.3.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031
  • 9.4 Europe Gene Therapy R&D Market Forecast by Vector
    • 9.4.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031
  • 9.5 Europe Gene Therapy R&D Market Forecast by Techniques
    • 9.5.1 Recovery Scenarios (V, U, W, L): Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031
  • 9.6 Germany Gene Therapy R&D Market Forecast, 2021-2031
    • 9.6.1 Germany Currently Dominates the European Gene Therapy R&D Market
    • 9.6.2 Rising Geriatric Patient Pool to Offer Lucrative Growth Prospects
    • 9.6.3 Increasing in New Pipeline Developments for Gene Therapy to Boost German Gene Therapy R&D Market
    • 9.6.4 Recovery Scenarios (V, U, W, L): Germany Gene Therapy R&D Market Forecast, 2021-2031
  • 9.7 UK Gene Therapy R&D Market Forecast, 2021-2031
    • 9.7.1 Rising Number of Clinical Trials to Boost UK Gene Therapy R&D Market Growth
    • 9.7.2 Rising Cancer Burden to Boost Regional Growth Over the Forecast Period
    • 9.7.3 Growing Burden of Genetic Disorders to Fuel Regional Growth Through 2031
    • 9.7.4 Recovery Scenarios (V, U, W, L): UK Gene Therapy R&D Market Forecast, 2021-2031
  • 9.8 France Gene Therapy R&D Market Forecast, 2021-2031
    • 9.8.1 Increasing Incidence of Genetic Disorders to Fuel French Gene Therapy R&D Market Growth
    • 9.8.2 Rising Cancer Incidence to Fuel Gene Therapy R&D Growth
    • 9.8.3 Presence of Major Biotech Firms Across France to Offer Lucrative Growth Prospects
    • 9.8.4 Recovery Scenarios (V, U, W, L): France Gene Therapy R&D Market Forecast, 2021-2031
  • 9.9 Italy Gene Therapy R&D Market Forecast, 2021-2031
    • 9.9.1 Italian Gene Therapy R&D Market to Surge Owing to Rising Healthcare Expenditure
    • 9.9.2 Italian Gene Therapy R&D Set to Witness Tremendous Growth
    • 9.9.3 Recovery Scenarios (V, U, W, L): Italy Gene Therapy R&D Market Forecast, 2021-2031
  • 9.10 Spain Gene Therapy R&D Market Forecast, 2021-2031
    • 9.10.1 Rising Cancer Burden to Fuel Spanish Gene Therapy R&D Industry Growth
    • 9.10.2 Recovery Scenarios (V, U, W, L): Spain Gene Therapy R&D Market Forecast, 2021-2031
  • 9.11 Russia Gene Therapy R&D Market Forecast, 2021-2031
    • 9.11.1 Rising Cancer Incidence to Fuel Russian Gene Therapy R&D Market Growth
    • 9.11.2 Government Focus to Establish Special Fund for Gene Therapy to Fuel Regional Growth
    • 9.11.3 Recovery Scenarios (V, U, W, L): Russia Gene Therapy R&D Market Forecast, 2021-2031
  • 9.12 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031
    • 9.12.1 Finland Gene Therapy R&D Another Promising Market in Rest of Europe
    • 9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031

10 Asia Pacific Gene Therapy R&D Market

  • 10.1 Asia Pacific to Witness Highest Growth Rates Through 2031
  • 10.2 Asia Pacific Gene Therapy R&D Market by Country, Forecast 2021-2031
  • 10.3 Asia Pacific Gene Therapy R&D Market Forecast by Disease
    • 10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031
  • 10.4 Asia Pacific Gene Therapy R&D Market Forecast by Vector
    • 10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031
  • 10.5 Asia Pacific Gene Therapy R&D Market Forecast by Techniques
    • 10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031
  • 10.6 Japan Gene Therapy R&D Market Forecast, 2021-2031
    • 10.6.1 Japanese Gene Therapy R&D Market to Witness Highest CAGR Through 2031
    • 10.6.2 Approval of Zolgensma by Japanese Government Anticipated to Boost Regional Growth
    • 10.6.3 Ageing Japanese Population Anticipated to Offer Lucrative Growth Prospects Over the Next Decade
    • 10.6.4 Recovery Scenarios (V, U, W, L): Japan Gene Therapy R&D Market Forecast, 2021-2031
  • 10.7 China Gene Therapy R&D Market Forecast, 2021-2031
    • 10.7.1 China Currently Accounts for Majority of the APAC Gene Therapy R&D Market Share
    • 10.7.2 Strategic Collaboration to Fuel Chinese Gene Therapy R&D Market Over the Forecast Period
    • 10.7.3 Recovery Scenarios (V, U, W, L): China Gene Therapy R&D Market Forecast, 2021-2031
  • 10.8 India Gene Therapy R&D Market Forecast, 2021-2031
    • 10.8.1 Burden of Genetic Disorders and Unmet Medical Needs to fuel Regional Gene Therapy R&D Industry Growth
    • 10.8.2 India Continues to be a Key Player in Gene Therapy Related Research
    • 10.8.3 Recovery Scenarios (V, U, W, L): India Gene Therapy R&D Market Forecast, 2021-2031
  • 10.9 Australia Gene Therapy R&D Market Forecast, 2021-2031
    • 10.9.1 Rising Chronic Disorders to Augur Australian Gene Therapy R&D Market Growth
    • 10.9.2 Australia is Currently Undergoing Gene Therapy Clinical Trials to Treat a Variety of Genetic Health Conditions
    • 10.9.3 Recovery Scenarios (V, U, W, L): Australia Gene Therapy R&D Market Forecast, 2021-2031
  • 10.10 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031
    • 10.10.1 SEA Economies Driving Rest of APAC Gene Therapy R&D Industry
    • 10.10.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031

11 Latin America Gene Therapy R&D Market

  • 11.1 Latin America Gene Therapy R&D Industry, One of the Emerging Regions Globally
    • 11.1.1 Brazil First Among Latin American Economy to Approve Luxturna® and Zolgensma®
  • 11.2 Latin America Gene Therapy R&D Market by Country, Forecast 2021-2031
  • 11.3 Latin America Gene Therapy R&D Market Forecast by Disease
    • 11.3.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031
  • 11.4 Latin America Gene Therapy R&D Market Forecast by Vector
    • 11.4.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031
  • 11.5 Latin America Gene Therapy R&D Market Forecast by Techniques
    • 11.5.1 Recovery Scenarios (V, U, W, L): Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031
  • 11.6 Brazil Gene Therapy R&D Market Forecast, 2021-2031
    • 11.6.1 Brazil Gene Therapy R&D Market to Witness Highest Growth Rate Across Latin American Region
    • 11.6.2 Recovery Scenarios (V, U, W, L): Brazil Gene Therapy R&D Market Forecast, 2021-2031
  • 11.7 Mexico Gene Therapy R&D Market Forecast, 2021-2031
    • 11.7.1 Mexican Gene Therapy R&D Currently Dominating the Latin American Region
    • 11.7.2 Burgeoning Ant-Aging Research to Offer Lucrative Growth Prospects
    • 11.7.3 Recovery Scenarios (V, U, W, L): Mexico Gene Therapy R&D Market Forecast, 2021-2031
  • 11.8 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031
    • 11.8.1 Recovery Scenarios (V, U, W, L): Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031

12 Middle East and Africa Gene Therapy R&D Market

  • 12.1 Growing Chronic Disease Patient Pool to Drive Demand for Gene Therapy R&D Industry Across MEA Region
  • 12.2 Middle East and Africa Gene Therapy R&D Market by Country, Forecast 2021-2031
  • 12.3 Middle East and Africa Gene Therapy R&D Market Forecast by Disease
    • 12.3.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031
  • 12.4 Middle East and Africa Gene Therapy R&D Market Forecast by Vector
    • 12.4.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031
  • 12.5 Middle East and Africa Gene Therapy R&D Market Forecast by Techniques
    • 12.5.1 Recovery Scenarios (V, U, W, L): MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031
  • 12.6 GCC Gene Therapy R&D Market Forecast, 2021-2031
    • 12.6.1 Rising Burden of Chronic Diseases to Fuel GCC Gene Therapy R&D Market Growth
    • 12.6.2 Luxturna Approval in UAE Anticipated to Boost Gene Therapy R&D Market Over the Next Decade
    • 12.6.3 Recovery Scenarios (V, U, W, L): GCC Gene Therapy R&D Market Forecast, 2021-2031
  • 12.7 South Africa Gene Therapy R&D Market Forecast, 2021-2031
    • 12.7.1 South Africa Currently Dominates the MEA Gene Therapy R&D Market
    • 12.7.2 Investment in South African Gene Therapy R&D Industry to Boost Regional Growth
    • 12.7.3 Recovery Scenarios (V, U, W, L): South Africa Gene Therapy R&D Market Forecast, 2021-2031
  • 12.8 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031
    • 12.8.1 Recovery Scenarios (V, U, W, L): Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031

13 Competitive Landscape

  • 13.1 Strategic Choices for Winning in Gene Therapy R&D Market
    • 13.1.1 Diversification of Technical Risks
    • 13.1.2 How to Achieve Long Term Benefits to Patients
    • 13.1.3 Building Digital Capabilities
    • 13.1.4 Mergers & Acquisitions to Offer Lucrative Growth Prospects for Players Across the Value Chain
  • 13.2 Approved Cellular & Gene Therapy Products as of March 2021
  • 13.3 Ongoing Gene Therapy Clinical Trials by Companies
  • 13.4 Gene Therapy Companies Market Capitalization

14 Company Profiles

  • 14.1 UniQure B. V.
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis, 2015-2019
    • 14.1.4 Pipeline: Gene Therapy
    • 14.1.5 Recent Developments
  • 14.2 Biogen
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis, 2015-2019
    • 14.2.4 Product Benchmarking
    • 14.2.5 Recent Developments
  • 14.3 Bluebird Bio
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis, 2015-2019
    • 14.3.4 Product Benchmarking
    • 14.3.5 Recent Developments
  • 14.4 Spark Therapeutics (Subsidiary of Roche)
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Product Benchmarking
    • 14.4.4 Recent Developments
  • 14.5 Bayer
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis, 2015-2020
    • 14.5.4 Product Benchmarking
    • 14.5.5 Recent Developments
  • 14.6 Pfizer, Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis, 2015-2020
    • 14.6.4 Product Benchmarking
    • 14.6.5 Recent Developments
  • 14.7 Applied Genetic
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis, 2015-2020
    • 14.7.4 Product Benchmarking
    • 14.7.5 Recent Developments
  • 14.8 Oxford Biomedica
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis, 2015-2019
    • 14.8.4 Product Pipeline
    • 14.8.5 Recent Developments
  • 14.9 GenSight Biologics
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Product Benchmarking
  • 14.10 Takeda Pharmaceuticals
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis, 2015-2020
    • 14.10.4 Product Benchmarking
    • 14.10.5 Recent Developments
  • 14.11 Cellectis
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis, 2015-2019
    • 14.11.4 Product Benchmarking
    • 14.11.5 Recent Developments
  • 14.12 Sangamo Therapeutics, Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis, 2015-2019
    • 14.12.4 Product Benchmarking
    • 14.12.5 Recent Developments
  • 14.13 REGENXBIO Inc.
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis, 2015-2019
    • 14.13.4 Product Benchmarking
    • 14.13.5 Recent Developments
  • 14.14 Voyager Therapeutics
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis, 2015-2019
    • 14.14.4 Product Benchmarking
    • 14.14.5 Recent Developments
  • 14.15 Bristol Myers Squibb
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis, 2015-2019
    • 14.15.4 Product Benchmarking
    • 14.15.5 Recent Developments
  • 14.16 Benitec BioPharma
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis, 2015-2020
    • 14.16.4 Product Benchmarking
  • 14.17 F. Hoffmann-La Roche Ltd.
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Financial Analysis, 2015-2019
    • 14.17.4 Product Benchmarking
    • 14.17.5 Recent Developments
  • 14.18 Novartis Gene Therapies
    • 14.18.1 Company Snapshot
    • 14.18.2 Company Overview
    • 14.18.3 Financial Analysis, 2015-2020
    • 14.18.4 Product Benchmarking
    • 14.18.5 Recent Developments
  • 14.19 Gilead Lifesciences, Inc.
    • 14.19.1 Company Snapshot
    • 14.19.2 Company Overview
    • 14.19.3 Financial Analysis, 2015-2019
    • 14.19.4 Product Benchmarking
  • 14.20 Sanofi
    • 14.20.1 Company Snapshot
    • 14.20.2 Company Overview
    • 14.20.3 Financial Analysis, 2015-2019
    • 14.20.4 Product Benchmarking
    • 14.20.5 Recent Developments
  • 14.21 Transgene
    • 14.21.1 Company Snapshot
    • 14.21.2 Company Overview
    • 14.21.3 Product Benchmarking
  • 14.22 Calimmune, Inc. (CSL Behiring)
    • 14.22.1 Company Snapshot
    • 14.22.2 Company Overview
    • 14.22.3 Product Benchmarking
    • 14.22.4 Recent Developments
  • 14.23 Astellas Pharma Inc.
    • 14.23.1 Company Snapshot
    • 14.23.2 Company Overview
    • 14.23.3 Financial Analysis, 2015-2020
    • 14.23.4 Product Benchmarking
  • 14.24 American Gene Technologies
    • 14.24.1 Company Snapshot
    • 14.24.2 Company Overview
    • 14.24.3 Product Benchmarking
  • 14.25 Orchard Therapeutics
    • 14.25.1 Company Snapshot
    • 14.25.2 Company Overview
    • 14.25.3 Product Benchmarking
    • 14.25.4 Recent Developments

15 Conclusion

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players
  • 15.3 Leading Region & Highest CAGR Grossing Region Snapshot, 2021 & 2031

List of Tables

  • Table 1 Global Gene Therapy R&D Market Snapshot, 2021 & 2031 (US$ million, CAGR %)
  • Table 1 Promising Therapies in Development
  • Table 2 Gene, Cell & Tissue Bases Therapeutic Developers Financings by IPOs, 2020
  • Table 3 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Follow-Ons, 2020
  • Table 4 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Venture Capital, 2020
  • Table 5 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Partnership, 2020
  • Table 6 Global Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 7 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 8 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 9 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 10 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 11 Gene Therapy R&D Market Forecast for Cancer Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 12 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 13 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 14 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 15 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 16 Global Gene Therapy R&D Market Forecast by Rare Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 17 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 18 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 19 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 20 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 21 Gene Therapy R&D Market Forecast for Cardiovascular Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 22 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 23 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 24 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 25 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 26 Gene Therapy R&D Market Forecast for Ophthalmic Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 27 Selected Gene Therapy Amenable Hematological Disorders
  • Table 28 Selected Gene Therapy Amenable Hematological Disorders
  • Table 29 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 30 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 31 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 32 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 33 Gene Therapy R&D Market Forecast for Hematology Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 34 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 35 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 36 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 37 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 38 Gene Therapy R&D Market Forecast for Neurological Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 39 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 40 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 41 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 42 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 43 Gene Therapy R&D Market Forecast for Diabetes Mellitus Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 44 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 45 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 46 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 47 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 48 Gene Therapy R&D Market Forecast for Other Diseases Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 49 Global Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 50 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 51 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 52 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 53 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 54 Global Gene Therapy R&D Market Forecast by Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 55 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 56 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 57 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 58 Global Gene Therapy R&D Market Forecast by Non-Viral Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 59 Global Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 60 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 61 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 62 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 63 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 64 Gene Therapy R&D Market Forecast for Gene Augmentation Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 65 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 66 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 67 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 68 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 69 Gene Therapy R&D Market Forecast for Gene Replacement Therapy Segment, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 70 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 71 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 72 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 73 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 74 Global Gene Therapy R&D Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 75 North America Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 76 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 77 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 78 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 79 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 80 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 81 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 82 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 83 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 84 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 85 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 86 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 87 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 88 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 89 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 90 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 91 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 92 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 93 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 94 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 95 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 96 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 97 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 98 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 99 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 100 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 101 Europe Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 102 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 103 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 104 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 105 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 106 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 107 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 108 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 109 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 110 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 111 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 112 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 113 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 114 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 115 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 116 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 117 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 118 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 119 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 120 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 121 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 122 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 123 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 124 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 125 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 126 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 127 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 128 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 129 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 130 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 131 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 132 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 133 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 134 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 135 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 136 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 137 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 138 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 139 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 140 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 141 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 142 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 143 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 144 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 145 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 146 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 147 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 148 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 149 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 150 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 151 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 152 Asia Pacific Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 153 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 154 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 155 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 156 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 157 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 158 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 159 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 160 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 161 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 162 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 163 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 164 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 165 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 166 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 167 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 168 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 169 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 170 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 171 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 172 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 173 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 174 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 175 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 176 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 177 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 178 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 179 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 180 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 181 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 182 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 183 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 184 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 185 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 186 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 187 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 188 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 189 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 190 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 191 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 192 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 193 Latin America Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 194 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 195 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 196 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 197 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 198 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 199 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 200 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 201 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 202 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 203 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 204 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 205 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 206 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 207 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 208 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 209 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 210 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 211 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 212 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 213 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 214 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 215 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 216 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 217 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 218 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 219 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 220 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 221 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 222 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 223 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 224 MEA Gene Therapy R&D Market Forecast by Country, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 225 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 226 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 227 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 228 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 229 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 230 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 231 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 232 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 233 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 234 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 235 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ mn, AGR%, CAGR%)
  • Table 236 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 237 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 238 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 239 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 240 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 241 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 242 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 243 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 244 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 245 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 246 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 247 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 248 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 249 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 250 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%)
  • Table 251 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 252 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 253 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 254 Rest of MEA Gene Therapy R&D Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 2 Approved Cellular & Gene Therapy Products as of March 2021
  • Table 3 Ongoing Gene Therapy Clinical Trials by Companies
  • Table 255 UniQure B. V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 256 UniQure B. V.: Product Benchmarking
  • Table 257 UniQure B. V.: Recent Developments
  • Table 258 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 259 Biogen: Product Benchmarking
  • Table 260 Biogen: Recent Developments
  • Table 261 Bluebird Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 262 Bluebird Bio: Product Benchmarking
  • Table 263 Bluebird Bio: Recent Developments
  • Table 264 Spark Therapeutics (Subsidiary of Roche): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 265 Spark Therapeutics: Product Benchmarking
  • Table 266 Spark Therapeutics: Recent Developments
  • Table 267 Bayer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 268 Bayer: Product Benchmarking
  • Table 269 Bayer: Recent Developments
  • Table 270 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 271 Pfizer Inc.: Product Benchmarking
  • Table 272 Pfizer Inc.: Recent Developments
  • Table 273 Applied Genetic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 274 Applied Genetic: Product Benchmarking
  • Table 275 Applied Genetic: Recent Developments
  • Table 276 Oxford Biomedica: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 277 Oxford Biomedica: Product Pipeline
  • Table 278 Oxford Biomedica: Recent Developments
  • Table 279 GenSight Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 280 GenSight Biologics: Product Benchmarking
  • Table 281 Takeda Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 282 Takeda Pharmaceuticals: Product Benchmarking
  • Table 283 Takeda Pharmaceuticals: Recent Developments
  • Table 284 Cellectis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 285 Cellectis: Product Benchmarking
  • Table 286 Cellectis: Recent Developments
  • Table 287 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 288 Sangamo Therapeutics, Inc.: Product Benchmarking
  • Table 289 Sangamo Therapeutics, Inc.: Recent Developments
  • Table 290 REGENXBIO Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 291 REGENXBIO Inc.: Product Benchmarking
  • Table 292 REGENXBIO Inc.: Recent Developments
  • Table 293 Voyager Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 294 Voyager Therapeutics: Product Benchmarking
  • Table 295 Voyager Therapeutics: Recent Developments
  • Table 296 Bristol Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 297 Bristol Myers Squibb: Product Benchmarking
  • Table 298 Bristol Myers Squibb: Recent Developments
  • Table 299 Benitec BioPharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 300 Benitec BioPharma: Product Benchmarking
  • Table 301 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 302 F. Hoffmann-La Roche Ltd.: Product Benchmarking
  • Table 303 F. Hoffmann-La Roche Ltd.: Recent Developments
  • Table 304 Novartis Gene Therapies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 305 Novartis AG: Product Benchmarking
  • Table 306 Novartis AG: Recent Developments
  • Table 307 Gilead Lifesciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 308 Gilead Lifesciences, Inc.: Product Benchmarking
  • Table 309 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 310 Sanofi: Product Benchmarking
  • Table 311 Sanofi: Recent Developments
  • Table 312 Transgene: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 313 Transgene: Product Benchmarking
  • Table 314 Calimmune, Inc. (CSL Behiring): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 315 Calimmune, Inc. (CSL Behiring): Product Benchmarking
  • Table 316 Calimmune, Inc. (CSL Behiring): Recent Developments
  • Table 317 Astellas Pharma Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 318 Astellas Pharma Inc.: Product Benchmarking
  • Table 319 American Gene Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 320 American Gene Technologies: Product Benchmarking
  • Table 321 Orchard Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 322 Orchard Therapeutics: Product Benchmarking
  • Table 323 Orchard Therapeutics: Recent Developments

List of Figures

  • Figure 1 Global Gene Therapy R&D Market: Market Segmentation
  • Figure 2 Global Gene Therapy R&D Market: Market Trends
  • Figure 3 Gene, Cell & Tissue Bases Therapeutic Developers Financings by Deal Type, 2020
  • Figure 4 Porter's Analysis
  • Figure 5 PEST Analysis
  • Figure 6 Global Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR %)
  • Figure 7 Global Gene Therapy R&D Market Share Forecast by Disease, 2021, 2026, 2031 (%)
  • Figure 8 Global Gene Therapy R&D Market for Cancer Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 9 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 10 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 11 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 12 Global Gene Therapy R&D Market for Cancer Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 13 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 14 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 15 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 16 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 17 Global Gene Therapy R&D Market for Rare Diseases Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 18 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 19 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 20 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 21 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 22 Global Gene Therapy R&D Market for Cardiovascular Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 23 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 24 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 25 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 26 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 27 Global Gene Therapy R&D Market for Ophthalmic Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 28 Global Gene Therapy R&D Market for Hematology Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 29 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 30 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 31 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 32 Global Gene Therapy R&D Market for Hematology Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 33 Global Gene Therapy R&D Market for Neurological Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 34 Global Gene Therapy R&D Market for Neurological Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 35 Global Gene Therapy R&D Market for Neurological Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 36 Global Gene Therapy R&D Market for Neurological Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 37 Global Gene Therapy R&D Market for Neurological Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 38 Global Gene Therapy R&D Market for Diabetes Mellitus Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 39 Global Gene Therapy R&D Market for Diabetes Mellitus Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 40 Global Gene Therapy R&D Market for Diabetes Mellitus Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 41 Global Gene Therapy R&D Market for Diabetes Mellitus Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 42 Global Gene Therapy R&D Market for Diabetes Mellitus Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 43 Global Gene Therapy R&D Market for Other Diseases Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 44 Global Gene Therapy R&D Market for Other Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 45 Global Gene Therapy R&D Market for Other Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 46 Global Gene Therapy R&D Market for Other Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 47 Global Gene Therapy R&D Market for Other Diseases Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 48 Global Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR %)
  • Figure 49 Global Gene Therapy R&D Market Share Forecast by Vector, 2021, 2026, 2031 (%)
  • Figure 50 Global Gene Therapy R&D Market for Viral Sub-Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 51 Global Gene Therapy R&D Market for Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 52 Global Gene Therapy R&D Market for Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 53 Global Gene Therapy R&D Market for Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 54 Global Gene Therapy R&D Market for Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 55 Global Gene Therapy R&D Market for Non-Viral Sub-Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 56 Global Gene Therapy R&D Market for Non-Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 57 Global Gene Therapy R&D Market for Non-Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 58 Global Gene Therapy R&D Market for Non-Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 59 Global Gene Therapy R&D Market for Non-Viral Sub-Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 60 Global Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR %)
  • Figure 61 Global Gene Therapy R&D Market Share Forecast by Techniques, 2021, 2026, 2031 (%)
  • Figure 62 Global Gene Therapy R&D Market for Gene Augmentation Therapy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 63 Global Gene Therapy R&D Market for Gene Augmentation Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 64 Global Gene Therapy R&D Market for Gene Augmentation Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 65 Global Gene Therapy R&D Market for Gene Augmentation Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 66 Global Gene Therapy R&D Market for Gene Augmentation Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 67 Global Gene Therapy R&D Market for Gene Replacement Therapy Segment: Revenue Forecast 2021-2031 (US$ million, AGR%)
  • Figure 68 Global Gene Therapy R&D Market for Gene Replacement Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 69 Global Gene Therapy R&D Market for Gene Replacement Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 70 Global Gene Therapy R&D Market for Gene Replacement Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 71 Global Gene Therapy R&D Market for Gene Replacement Therapy Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 72 Global Gene Therapy R&D Market Forecast by Region 2021-2031 (US$ million)
  • Figure 73 Global Gene Therapy R&D Market Share Forecast by Region 2021, 2026, 2031 (%)
  • Figure 74 Global Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 75 Global Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 76 Global Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 77 Global Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 78 North America Gene Therapy R&D Market Forecast by Country 2021-2031 (US$ million)
  • Figure 79 North America Gene Therapy R&D Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 80 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%)
  • Figure 81 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 82 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 83 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 84 North America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 85 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%)
  • Figure 86 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 87 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 88 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 89 North America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 90 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%)
  • Figure 91 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 92 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 93 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 94 North America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 95 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 96 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 97 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 98 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 99 U.S. Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 100 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 101 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 102 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 103 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 104 Canada Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 105 Europe Gene Therapy R&D Market Forecast by Country 2021-2031 (US$ million)
  • Figure 106 Europe Gene Therapy R&D Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 107 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%)
  • Figure 108 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 109 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 110 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 111 Europe Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 112 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%)
  • Figure 113 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 114 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 115 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 116 Europe Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 117 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%)
  • Figure 118 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 119 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 120 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 121 Europe Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 122 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 123 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 124 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 125 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 126 Germany Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 127 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 128 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 129 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 130 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 131 UK Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 132 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 133 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 134 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 135 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 136 France Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 137 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 138 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 139 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 140 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 141 Italy Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 142 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 143 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 144 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 145 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 146 Spain Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 147 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 148 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 149 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 150 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 151 Russia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 152 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 153 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 154 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 155 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 156 Rest of Europe Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 157 Asia Pacific Gene Therapy R&D Market Forecast by Country 2021-2031 (US$ million)
  • Figure 158 Asia Pacific Gene Therapy R&D Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 159 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%)
  • Figure 160 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 161 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 162 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 163 Asia Pacific Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 164 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%)
  • Figure 165 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 166 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 167 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 168 Asia Pacific Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 169 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%)
  • Figure 170 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 171 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 172 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 173 Asia Pacific Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 174 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 175 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 176 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 177 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 178 Japan Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 179 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 180 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 181 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 182 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 183 China Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 184 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 185 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 186 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 187 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 188 India Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 189 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 190 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 191 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 192 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 193 Australia Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 194 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 195 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 196 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 197 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 198 Rest of Asia Pacific Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 199 Latin America Gene Therapy R&D Market Forecast by Country 2021-2031 (US$ million)
  • Figure 200 Latin America Gene Therapy R&D Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 201 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%)
  • Figure 202 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 203 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 204 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 205 Latin America Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 206 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%)
  • Figure 207 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 208 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 209 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 210 Latin America Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 211 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%)
  • Figure 212 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 213 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 214 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 215 Latin America Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 216 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 217 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 218 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 219 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 220 Brazil Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 221 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 222 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 223 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 224 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 225 Mexico Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 226 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 227 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 228 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 229 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 230 Rest of Latin America Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 231 Middle East and Africa Gene Therapy R&D Market Forecast by Country 2021-2031 (US$ million)
  • Figure 232 Middle East and Africa Gene Therapy R&D Market Share Forecast by Country 2021, 2026, 2031 (%)
  • Figure 233 Middle East and Africa Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%)
  • Figure 234 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 235 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 236 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 237 MEA Gene Therapy R&D Market Forecast by Disease, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 238 Middle East and Africa Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%)
  • Figure 239 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 240 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 241 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 242 MEA Gene Therapy R&D Market Forecast by Vector, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 243 Middle East and Africa Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%)
  • Figure 244 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 245 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 246 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 247 MEA Gene Therapy R&D Market Forecast by Techniques, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 248 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 249 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 250 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 251 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 252 GCC Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 253 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 254 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 255 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 256 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 257 South Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 258 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR %)
  • Figure 259 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "V" Shaped Recovery
  • Figure 260 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "U" Shaped Recovery
  • Figure 261 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "W" Shaped Recovery
  • Figure 262 Rest of Middle East and Africa Gene Therapy R&D Market Forecast, 2021-2031 (US$ million, AGR%): "L" Shaped Recovery
  • Figure 263 M&A activity in the cell and gene therapy industry, 2019
  • Figure 264 Gene Therapy Companies Market Cap in US$ bn
  • Figure 265 Gene Therapy Companies Market Cap in US$ bn
  • Figure 266 UniQure B. V.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 267 Biogen: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 268 Bluebird Bio: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 269 Bayer: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 270 Pfizer Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 271 Applied Genetic: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 272 Oxford Biomedica: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 273 Takeda Pharmaceuticals: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 274 Cellectis: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 275 Sangamo Therapeutics, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 276 REGENXBIO Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 277 Voyager Therapeutics: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 278 Bristol Myers Squibb: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 279 Benitec BioPharma: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 280 F. Hoffmann-La Roche Ltd.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 281 Novartis AG: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 282 Gilead Lifesciences, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 283 Sanofi: Net Revenue, 2015-2019 (US$ million, AGR%)
  • Figure 284 Astellas Pharma Inc.: Net Revenue, 2015-2020 (US$ million, AGR%)
  • Figure 285 Leading Region & Highest CAGR Grossing Region Snapshot, 2021-2031

Companies Profiled in the Report:

  • American Gene Technologies
  • Applied Genetic
  • Astellas Pharma Inc.
  • Bayer
  • Benitec BioPharma
  • Biogen
  • Bluebird Bio
  • Bristol Myers Squibb
  • Calimmune, Inc. (CSL Behiring)
  • Cellectis
  • F. Hoffmann-La Roche Ltd.
  • GenSight Biologics
  • Gilead Lifesciences, Inc.
  • Novartis AG
  • Orchard Therapeutics
  • Oxford Biomedica
  • Pfizer, Inc.
  • REGENXBIO Inc.
  • Sangamo Therapeutics, Inc.
  • Sanofi
  • Spark Therapeutics (Subsidiary of Roche)
  • Takeda Pharmaceuticals
  • Transgene
  • UniQure B. V.
  • Voyager Therapeutics

List of Other Companies:

  • Abeona Therapeutics
  • Acucela
  • Adaptimmune Therapeutics
  • Autolus
  • AveXis
  • BioCancell
  • Biomay
  • Biomiga
  • BioReliance
  • Biotec Services International
  • Celladon
  • Cellectis
  • Cellular Biomedicine Group
  • Delphi Genetics
  • Department of Neuroscience, University of Minnesota
  • Desktop Genetics
  • DNAtrix
  • Elixirgen Scientific
  • Epeius Biotechnologies
  • EUFETS
  • Eurofins Genomics
  • European Society of Gene and Cell Therapy
  • GEG Tech
  • Genable Technologies
  • Immune Design
  • Immune Technology
  • ImmunoGenes
  • Immunomic Therapeutics
  • Inbiomed
  • Indiana University Vector Production Facility
  • VIVEbiotech
  • Voyager Therapeutics
  • Waisman Biomanufacturing
  • Xpress Biologics

List of Organizations:

  • American Society of Gene & Cell Therapy (ASGCT)
  • British Society for Gene and Cell Therapy (BSGCT)
  • European Society of Gene and Cell Therapy (ESGCT)
  • Gene Therapy Net
  • Informa UK Limited
  • IntechOpen
  • International Society for Cell & Gene Therapy (ISCT)
  • JOURNAL OF GENERAL VIROLOGY
  • Massachusetts Medical Society
  • National Center for Biotechnology Information
  • Pan European Networks Ltd
  • Pharma Manufacturing
  • Pharmaceutical-Networking.com
  • The Alliance for Regenerative Medicine
  • The Royal Society